Search

Edwards Lifesciences Corp

Fechado

SetorSaúde

85.57 -0.67

Visão Geral

Variação de preço das ações

24h

Atual

Mín

85.41

Máximo

87.2

Indicadores-chave

By Trading Economics

Rendimento

-139M

241M

Vendas

92M

1.7B

P/E

Médio do Setor

51.923

47.946

EPS

0.78

Margem de lucro

13.866

Funcionários

16,000

EBITDA

20M

520M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+20.34% upside

Dividendos

By Acuity

Próximos Ganhos

4 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

1.3B

50B

Abertura anterior

86.24

Fecho anterior

85.57

Sentimento de Notícias

By Acuity

57%

43%

267 / 340 Ranking em Healthcare

Edwards Lifesciences Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

6 de out. de 2026, 19:15 UTC

Edwards Lifesciences Corp shares are declining, following unusual volatility, and have fallen to their lowest point of the day amid a cumulative loss since Monday.

5 de out. de 2026, 20:02 UTC

Social Media
News

Edwards Lifesciences plans an investor event on November 2, 2026, and is on Citi's 90-Day Upside Catalyst Watch List, contributing to its higher trading today.

2 de out. de 2026, 20:07 UTC

News

Edwards Lifesciences shares fell despite FDA approval of the AUTUS Size-Adjustable Valve for pediatric patients, designed to reduce the need for multiple surgeries.

1 de out. de 2026, 20:02 UTC

Edwards Lifesciences Corp shares fell sharply, pulling back from an early gain and trading below the 20-day moving average, nearing the lower end of its one-month range.

30 de set. de 2026, 20:07 UTC

Edwards Lifesciences Corp shares fell sharply, continuing a downward trend and remaining below their 20-day moving average despite a brief recovery earlier in the session.

29 de set. de 2026, 22:01 UTC

Edwards Lifesciences Corp is trading modestly lower in after-market hours, with its cumulative return showing more pronounced losses following four consecutive higher sessions.

28 de set. de 2026, 21:21 UTC

Edwards Lifesciences Corp traded modestly lower during after-market hours, remaining 1.39% below its 20-day moving average.

23 de set. de 2026, 20:02 UTC

Edwards Lifesciences Corp shares fell sharply, remaining well below their 20-day moving average and near the lower end of their one-month range.

22 de set. de 2026, 23:01 UTC

Edwards Lifesciences Corp is trading modestly higher in after-market hours, nearing the upper end of its one-month trading range.

17 de set. de 2026, 20:07 UTC

Edwards Lifesciences Corp shares fell sharply on Thursday, continuing a downward trend that began after Wednesday's close, despite peaking in the morning.

16 de set. de 2026, 23:41 UTC

Edwards Lifesciences Corp saw a modest decline in after-hours trading, continuing a downward trend that has intensified since Wednesday's close.

15 de set. de 2026, 20:51 UTC

Edwards Lifesciences shares are lower in after-market trading. Broader market sentiment is pressured by rising crude oil prices amid geopolitical tensions in the Middle East.

14 de set. de 2026, 20:08 UTC

Edwards Lifesciences Corp shares are higher during Monday's session, reflecting an upward trend since Friday's close, despite being below the 20-day moving average.

11 de set. de 2026, 20:02 UTC

News

Edwards Lifesciences shares are lower despite receiving an Overweight rating and a $101 price target from Piper Sandler amid mixed TAVR coverage sentiment.

8 de set. de 2026, 20:02 UTC

Correlated Moves

Edwards Lifesciences Corp is declining in Tuesday's session, mirroring broader losses in the medical devices sector and trading below its 20-day moving average.

2 de set. de 2026, 19:16 UTC

Shares of Edwards Lifesciences Corp. are lower today amid broader market pressures from rising bond yields, reflecting a routine trading pattern.

31 de ago. de 2026, 19:56 UTC

News

Edwards Lifesciences Corp shares are higher today, continuing momentum from Friday. The broader health care equipment sector is also showing strength.

26 de ago. de 2026, 19:56 UTC

Edwards Lifesciences is trading higher, despite a slight pullback from earlier session highs. The stock remains above its 20-day moving average.

24 de ago. de 2026, 19:16 UTC

Edwards Lifesciences Corp shares are higher, continuing positive momentum since Friday's close, despite pulling back from an earlier session high.

20 de ago. de 2026, 20:01 UTC

Edwards Lifesciences Corp shares are lower, driven by a decline in the Health Care Equipment sub-sector and ongoing market weakness since Wednesday's close.

19 de ago. de 2026, 19:26 UTC

Edwards Lifesciences Corp shares are higher during Wednesday's trading session, showing notable volatility while remaining above their 20-day moving average.

18 de ago. de 2026, 23:06 UTC

Edwards Lifesciences shares are lower in after-market hours amid rising U.S. bond yields, contributing to market concerns despite recent softer economic data.

13 de ago. de 2026, 20:06 UTC

Edwards Lifesciences shares are lower today, tracking a broader market decline. The stock remains above its 20-day moving average and near its one-month range.

12 de ago. de 2026, 22:16 UTC

Edwards Lifesciences shares declined in after-market trading, despite earlier fluctuations. The stock remains above its 20-day moving average and near its one-month range.

11 de ago. de 2026, 19:21 UTC

Edwards Lifesciences Corp is trading higher, maintaining upward momentum after four consecutive daily gains and peaking in the late morning session.

10 de ago. de 2026, 19:51 UTC

Edwards Lifesciences shares are higher today, reflecting unusual strength above the 20-day moving average amid uncertainty over the Federal Reserve's interest rate policy.

7 de ago. de 2026, 19:16 UTC

Edwards Lifesciences Corp. shares are higher today, fluctuating within a routine range since Thursday's close, currently trading above its 20-day moving average.

5 de ago. de 2026, 19:56 UTC

Edwards Lifesciences shares are lower today, continuing a decline since Tuesday. The stock remains above its 20-day moving average.

4 de ago. de 2026, 19:36 UTC

Edwards Lifesciences shares are higher amid positive market momentum, despite a notable decline in U.S. core factory orders reflecting weakening demand across sectors.

3 de ago. de 2026, 22:02 UTC

Edwards Lifesciences Corp shares are lower in after-market hours, following a notable decline that reached a session low shortly after the market opened.

Comparação entre Pares

Variação de preço

Edwards Lifesciences Corp Previsão

Preço-alvo

By TipRanks

20.34% parte superior

Previsão para 12 meses

Média 104.067 USD  20.34%

Máximo 110 USD

Mínimo 85 USD

Com base em 17 analistas de Wall Street que oferecem metas de preço de 12 meses para Edwards Lifesciences Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

17 ratings

14

Comprar

3

Manter

0

Vender

Sentimento

By Acuity

267 / 340 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.